Search Results - "Nieuwlaat, W A"

Low prevalence of hypopituitarism after traumatic brain injury: a multicenter study by Kokshoorn, N E, Smit, J W A, Nieuwlaat, W A, Tiemensma, J, Bisschop, P H, Groote Veldman, R, Roelfsema, F, Franken, A A M, Wassenaar, M J E, Biermasz, N R, Romijn, J A, Pereira, A M

“…ObjectiveHypopituitarism after traumatic brain injury (TBI) is considered to be a prevalent condition. However, prevalence rates differ considerably among…”
Get full text

Virilization due to ovarian androgen hypersecretion in a patient with ectopic adrenocorticotrophic hormone secretion caused by a carcinoid tumour: Case Report by Netea-Maier, R.T., Nieuwlaat, W.-A., Sweep, C.G.J., Wesseling, P., Massuger, L., Hermus, A.R.M.M.

“…A 52-year-old woman presented with symptoms of virilization, which had been ongoing for 5 months. At the age of 34 years, she had a large abdominal carcinoid…”
Get full text

Treatment of Nonfunctional Pituitary Adenoma Postoperative Remnants: Adjuvant or Delayed Gamma Knife Radiosurgery? by Sadik, Z.H.A., Voormolen, E.H.J., Depauw, P.R.A.M., Burhani, B., Nieuwlaat, W.A., Verheul, J., Leenstra, S., Fleischeuer, R., Hanssens, P.E.J.

“…It is still not clear whether Gamma Knife radiosurgery (GKRS) for nonfunctional pituitary adenomas should be used as a standard adjuvant postoperative therapy…”
Get full text

Unmet information needs and impact of cancer in (long-term) thyroid cancer survivors: results of the PROFILES registry by Husson, O., Mols, F., Oranje, W. A., Haak, H. R., Nieuwlaat, W. A., Netea-Maier, R. T., Smit, J. W. A., van de Poll-Franse, L. V.

“…Objective The objective of this study was to provide insight into the following: (a) the perceived level of, satisfaction with, and helpfulness of received…”
Get full text

Quantitative detection of peripheral thyroglobulin mRNA has limited clinical value in the follow-up of thyroid cancer patients by Span, P N, Sleegers, M J M, van den Broek, W J, Ross, H A, Nieuwlaat, W-A, Hermus, A R M M, Sweep, C G J

“…As recurrences after treatment for differentiated thyroid cancer can occur many years after thyroidectomy, periodic monitoring of serum thyroglobulin (Tg)…”
Get more information

Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter by HUYSMANS, Dyde A, NIEUWLAAT, Willy-Anne, ERDTSIECK, Ronald J, SCHELLEKENS, Andries P, BUS, Jo W, BRAVENBOER, Bert, HERMUS, Ad R

“…Radioiodine (131I) is increasingly used as treatment for volume reduction of nontoxic, nodular goiter. A high dose of 131I is often needed because of low…”
Get full text

Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters by NIEUWLAAT, Willy-Anne, HERMUS, Ad R, SIVRO-PRNDELJ, Ferida, CORSTENS, Frans H, HUYSMANS, Dyde A

“…In a recent study, we demonstrated that pretreatment with a single, low dose of recombinant human TSH (rhTSH) doubles 24-h thyroid radioactive iodine uptake in…”
Get full text

Unmet information needs and impact of cancer in (long-term) thyroid cancer survivors: results of the PROFILES registry: Information needs and impact of cancer by Husson, O., Mols, F., Oranje, W. A., Haak, H. R., Nieuwlaat, W. A., Netea-Maier, R. T., Smit, J. W. A., van de Poll-Franse, L. V.

Get full text

Pretreatment with a Single, Low Dose of Recombinant Human Thyrotropin Allows Dose Reduction of Radioiodine Therapy in Patients with Nodular Goiter by Bonnema, Steen J., Nielsen, Viveque E., Hegedüs, Laszlo

Get full text

Pretreatment with a Single, Low Dose of Recombinant Human Thyrotropin Allows Dose Reduction of Radioiodine Therapy in Patients with Nodular Goiter by Nieuwlaat, Willy-Anne, Huysmans, Dyde A., van den Bosch, Harrie C., Sweep, C. G. (Fred), Ross, H. Alec, Corstens, Frans H., Hermus, Ad R.

“…In patients with nodular goiter, radioiodine (131I) therapy results in a mean reduction in thyroid volume (TV) of approximately 40% after 1 yr. We have…”
Get full text

Dosimetry of Radioiodine Therapy in Patients with Nodular Goiter After Pretreatment with a Single, Low Dose of Recombinant Human Thyroid-Stimulating Hormone by Nieuwlaat, Willy-Anne, Hermus, Ad R, Ross, H. Alec, Buijs, Wilhelmina C, Edelbroek, Michela A, Bus, Jo W, Corstens, Frans H, Huysmans, Dyde A

“…A single, low dose of recombinant human thyroid-stimulating hormone (rhTSH) doubles 24-h RAIU and causes a more homogeneous distribution of radioiodine on…”
Get full text

Medical Mystery — The Answer by Nieuwlaat, Willy-Anne, Pieters, Gerlach

“…To the Editor: The medical mystery in the July 1 issue 1 involved 50-year-old identical twins (Figure 1A). The patient is the twin on the left side of the…”
Get full text

Towards larger volume reduction of nodular goitres by radioiodine therapy: a role for pretreatment with recombinant human thyrotropin? by Huysmans, Dyde A., Nieuwlaat, Willy-Anne, Hermus, Ad R.

Get full text

Authors’ Response: Pretreatment with a Single, Low Dose of Recombinant Human Thyrotropin Allows Dose Reduction of Radioiodine Therapy in Patients with Nodular Goiter by Nieuwlaat, Willy-Anne, Huysmans, Dyde A., Hermus, Ad R.

Get full text

Nontoxic, Nodular Goiter: New Management Paradigms by Nieuwlaat, Willy-Anne, Hermus, Ad R., Huysmans, Dyde A.

Get full text